D
AbCellera Biologics Inc. ABCL
$4.39 $0.092.09% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 133.29% -57.45% -44.98% -1.39% -27.18%
Total Other Revenue -- -- -- -- --
Total Revenue 133.29% -57.45% -44.98% -1.39% -27.18%
Cost of Revenue -4.19% 8.17% -5.24% 8.05% 12.21%
Gross Profit 34.15% -30.44% -4.01% -10.04% -27.21%
SG&A Expenses -5.75% -7.96% 0.47% 24.92% 20.48%
Depreciation & Amortization -85.02% 10.05% -357.90% 543.75% 551.02%
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -33.85% 3.16% -39.12% 62.91% 64.01%
Operating Income 46.94% -14.15% 38.30% -70.64% -81.86%
Income Before Tax 24.58% -23.95% 3.65% -59.47% -26.79%
Income Tax Expenses 85.64% -244.55% -769.08% -8.05% -50.58%
Earnings from Continuing Operations 5.97% -12.34% 27.44% -78.63% -20.97%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 5.97% -12.34% 27.44% -78.63% -20.97%
EBIT 46.94% -14.15% 38.30% -70.64% -81.86%
EBITDA 22.51% -14.54% 55.50% -15.44% -24.36%
EPS Basic 7.33% -10.45% 28.69% -75.40% -18.73%
Normalized Basic EPS 25.68% -21.80% 46.62% -97.76% -24.57%
EPS Diluted 7.69% -9.43% 31.80% -73.30% -18.18%
Normalized Diluted EPS 25.68% -21.80% 46.62% -97.76% -24.57%
Average Basic Shares Outstanding 1.46% 1.70% 1.76% 1.85% 1.84%
Average Diluted Shares Outstanding 1.46% 1.70% 1.76% 1.85% 1.84%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --